학술논문

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
Document Type
Article
Author
Molina, J.-M.Squires, K.Sax, P.E.Cahn, P.Lombaard, J.DeJesus, E.Lai, M.-T.Xu, X.Rodgers, A.Lupinacci, L.Kumar, S.Sklar, P.Nguyen, B.-Y.Hanna, G.J.Hwang, C.Martins, M.Cahn, P.E.Lopardo, G.D.Porteiro, N.Bloch, M.T.Baker, D.A.Roth, N.Moore, R.J.Finlayson, R.J.McMahon, J.Rieger, A.Zoufaly, A.Hartl, S.Zangerle, R.Smaill, F.Walmsley, S.L.Conway, B.Rachlis, A.Smith, G.H.R.Perez, C.Afani, A.Campos Barker, M.I.E.Chahin, C.E.Wolff Reyes, M.Gerstoft, J.Weis, N.Laursen, A.L.Molina, J.-M.Yazdanpanah, Y.Cotte, L.Raffi, F.Morlat, P.Girard, P.-M.Katlama, C.Rockstroh, J.K.Arasteh, K.Esser, S.Stoehr, A.Stellbrink, H.-J.Stoll, M.Schuermann, D.Faetkenheuer, G.Bogner, J.Lutz, T.Baumgarten, A.Jaeger, H.Gori, A.Coltan, G.Constandis, F.Erscoiu, S.M.Prisacariu, L.-J.Rugina, S.Streinu-Cercel, A.Pokrovsky, V.V.Zakharova, N.V.Shuldyakov, A.A.Ryamova, E.P.Kulagin, V.V.Tsybakova, O.A.Orlova-Morozova, E.Nagimova, F.Voronin, E.Shimonova, T.E.Kozyrev, O.A.Orrell, C.Lombaard, J.J.Botes, M.E.Portilla, J.Gatell, J.M.Perez, M.J.Arribas, J.R.Negredo, E.Podzamczer, D.Pulido, F.Troya, J.De los Santos, I.Berenguer, J.Williams, I.G.Johnson, M.A.Schembri, G.Clarke, A.Gompels, M.Fox, J.M.Taylor, S.J.Kegg, S.Hagins, D.P.Osiyemi, O.O.Prelutsky, D.J.Ramgopal, M.N.Dretler, R.DeJesus, E.Sloan, L.Lewis, S.T.Clay, P.G.Bellos, N.C.Thompson, M.A.Montero, J.McDonald, C.K.Creticos, C.Shamblaw, D.Terrelonge, A.E.Valdes, M.Tashima, K.T.Robbins, W.J.Felizarta, F.A.Elion, R.A.Slim, J.Lalezari, J.P.Lalla-Reddy, S.N.Ruane, P.J.Mills, A.Cade, J.L.Campo, R.E.Dietz, C.A.Blick, G.Mayer, C.Rondon, J.C.Cook, P.P.Daar, E.Kumar, P.N.Swindells, S.Castro, J.G.Morales-Ramirez, J.O.Santiago, L.Santana-Bagur, J.L.
Source
In: The Lancet HIV. (The Lancet HIV, May 2018, 5(5):e211-e220)
Subject
Language
English
ISSN
23523018